Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Rodman (Horsham, United Kingdom). Lessons from transgenic models of pulmonary hypertension. Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling

Member's Comments

No comment yet.

Related content which might interest you: Pathogenesis of pulmonary arterial hypertension: lessons from cancer Source: Eur Respir Rev 2013; 22: 543-551 Year: 2013 Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Lessons learned from trials of anti-remodelling drugs in pulmonary arterial hypertension Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases Year: 2019 R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models Source: Eur Respir J, 57 (5) 2003271; 10.1183/13993003.03271-2020 Year: 2021 Two rat models of hemolysis-induced pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 A novel murine model of severe pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001 Contemporary pathology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170050; 10.1183/16000617.0050-2017 Year: 2017 Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Inflammatory changes in a murine model of monocrotaline-induced pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 365s Year: 2005 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 An investigation of the origins of pulmonary artery lesion cells in pulmonary arterial hypertension rat models Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Audit of disease targeted therapies in adult patients with pulmonary arterial hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016